Sarv Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 5414.96%
- Profit Growth 196.65%
- Ebitda 199.43%
- Net Worth 2147.09%
- Total Assets 717.98%
About Sarv Lifesciences
Sarv Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2020 (Four years and two months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Nasa and Rachana Paul serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2020PTC373721
-
Company No.
373721
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sarv Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Nasa
|
Director | 25-Nov-2020 | Current |
|
Rachana Paul
|
Director | 25-Nov-2020 | Current |
Financial Performance of Sarv Lifesciences.
Sarv Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 5414.96% increase. The company also saw a substantial improvement in profitability, with a 196.65% increase in profit. The company's net worth Soared by an impressive increase of 2147.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarv Lifesciences?
In 2022, Sarv Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Luvya Medicare Private LimitedSeema Nasa is a mutual person
-
Medlay Healthcare Private LimitedSeema Nasa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarv Lifesciences?
Sarv Lifesciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarv Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarv Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.